Exploratory Study of Cellular Reservoirs in Blood From HIV Infected Patients
NCT02858414 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41
Last updated 2018-12-06
Summary
This study evaluates the impact of highly active antiretroviral therapy on the size of the latent viral reservoirs in resting CD4+ T cells and monocytes in HIV positive patients. The activation state of the cells will be assessed, by measuring the activation of Akt, to determine its influence on the size of the viral reservoirs.
Conditions
- HIV Infection
Interventions
- OTHER
-
additional blood sample
Sponsors & Collaborators
-
Centre Hospitalier Universitaire de Besancon
lead OTHER
Principal Investigators
-
Georges HERBEIN, MD-PhD · Centre Hospitalier Universitaire de Besancon
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-04-02
- Primary Completion
- 2017-10-04
- Completion
- 2017-10-04
Countries
- France
Study Locations
More Related Trials
-
An Immunologic Study of Treatment-Naive HIV Patients Starting a Darunavir/Ritonavir- or Efavirenz-Based HAART
NCT01541085 ·Status: COMPLETED
-
Effects of Dolutegravir Based Regimen on HIV-1 Reservoir and Immune Activation
NCT02557997 ·Status: UNKNOWN
-
Effect Of An Integrase Inhibitor On The Latency And Reservoir Of HIV-1
NCT00807443 ·Status: COMPLETED ·Phase: PHASE2
-
CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes
NCT00966160 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Innovative Combinatorial stratégies of Anti-latency and Anti-immune Activation Drugs Targeting HIV Reservoir
NCT04741100 ·Status: WITHDRAWN
-
Preliminary Study of Early, Primary HIV Infection in a High Risk Cohort
NCT00989144 ·Status: COMPLETED
-
Impact of Pre-ART Blood CD4+ T Cell Level on the Rectal Reservoir in Long-term HIV-1 Treated Men
NCT02526940 ·Status: COMPLETED
-
Early ART to Limit Infection and Establishment of Reservoir
NCT02859558 ·Status: COMPLETED ·Phase: PHASE2
-
Administration of High Doses of Antiretroviral Drugs to Eliminate the Latent HIV-1 Reservoir
NCT06640192 ·Status: RECRUITING ·Phase: PHASE2
-
Observational Study on Anti-Tat Immune Response in HIV-1-infected HAART-treated Adult Subjects
NCT01024556 ·Status: COMPLETED
-
LoViReT (Low Viral Reservoir Treated Patients)
NCT02972931 ·Status: COMPLETED
-
Effect of Dolutegravir Intensification on HIV-1 Reservoirs
NCT05351684 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety of the HIV-1 Vaccine MVA-B in Chronic HIV-1 Infected Patients Successfully Treated With HAART
NCT01571466 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
NCT07053384 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Efficacy, and Safety Study of Optimized Background Antiretroviral Regimen (OB) in Combination With Enfuvirtide in the Treatment-Experienced Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection
NCT02733419 ·Status: COMPLETED ·Phase: PHASE3
-
Tucaresol As Add-On To HAART (Highly Active Antiretroviral Therapy) In Chronic HIV-1 Infected Adults
NCT00343941 ·Status: COMPLETED ·Phase: PHASE2
-
Reducing the Residual Reservoir of HIV-1 Infected Cells in Patients Receiving Antiretroviral Therapy
NCT02471430 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Dynamics of Drug Resistance-associated Mutations in HIV-1 DNA Reverse Transcriptase Clearance During Effective Antiretroviral Therapy
NCT04448158 ·Status: COMPLETED
-
A Long-term Follow-up of the HIV-NAT Cohort
NCT00411983 ·Status: RECRUITING
-
ANRS 12406 EvvA Study
NCT04593979 ·Status: UNKNOWN
-
Development of a New Family of HIV Latency Regulators (LRAs) Targeting the Tat Viral Protein
NCT06441123 ·Status: RECRUITING
-
The Use of Leukapheresis to Support HIV Pathogenesis Studies
NCT01161199 ·Status: RECRUITING
-
Study in HIV1-Positive, Virosuppressed Patients Currently inTreatment With Ritonavir-Boosted Protease Inhibitors (PI/r) Starting Cobicistat-Boosted Darunavir (DRV/c - Rezolsta)
NCT02926456 ·Status: COMPLETED
-
Evaluation of a Dose Reduction of Darunavir (400 mg/d) in Virologically Suppressed HIV-1 Patients
NCT02384967 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing Immune Activation and Latent HIV Reservoir Size Between People Living With HIV on Tenofovir-containing Versus NRTI-free ART
NCT05584397 ·Status: ENROLLING_BY_INVITATION